Antigen Express is a platform and product-based company developing proprietary vaccine formulations for large, unmet medical needs. Their focus is on stimulating critical members of the immune response, known as T helper cells. The technology allows for antigen-specific stimulation or suppression of a T-helper response to virtually any antigen of known pathogenic potential. Consequential, Antigen Express is building a deep pipeline of therapeutics aimed at a variety of major diseases, including cancer, infectious diseases and autoimmune-based syndromes. Antigen Express therapies are based on highly selective modulation of the immune response, in contrast to most current immunomodulation strategies that are in general non-specific. This lack of specificity is the prime source for unwanted side effects. The therapies developed at Antigen Express intervene at the critical stage of antigen presentation to modulate the immune response. This targeted approach results in a potent up or down regulation of critical members of the immune system. The technologies developed at Antigen Express are novel and highly complementary to existing approaches of immune modification. Therefore, the company is uniquely positioned to develop partnerships where Antigen Express technology enhances or augments the corporate partners’ technology or product portfolios.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of NuGenerex Immuno-Oncology Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. NuGenerex Immuno-Oncology Inc market cap is $10,000.00.
What is the 52-week high for NuGenerex Immuno-Oncology Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. NuGenerex Immuno-Oncology Inc 52 week high is $0.30 as of April 24, 2024.
What is the 52-week low for NuGenerex Immuno-Oncology Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NuGenerex Immuno-Oncology Inc 52 week low is $0.00 as of April 24, 2024.
What is NuGenerex Immuno-Oncology Inc stock price today?
NuGenerex Immuno-Oncology Inc stock price today is $0.0001.
What was NuGenerex Immuno-Oncology Inc stock price yesterday?
NuGenerex Immuno-Oncology Inc stock price yesterday was $0.0001.
What is the 50-day moving average of NuGenerex Immuno-Oncology Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. NuGenerex Immuno-Oncology Inc 50-day moving average is $0.0152.